Germán
Bou Arévalo
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublicacións en colaboración con investigadores/as de Hospital Clínico Universitario Lozano Blesa (7)
2024
-
Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial
The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385
2023
-
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370
2022
-
Justification for 24/7 clinical microbiology services
Enfermedades Infecciosas y Microbiologia Clinica
2020
-
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187
2018
-
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals
Clinical Microbiology and Infection, Vol. 24, Núm. 10, pp. 1070-1076
2016
-
Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain
Journal of Infection, Vol. 72, Núm. 2, pp. 152-160
2014
-
Detection of carbapenemase-producing Enterobacteriaceae in various scenarios and health settings
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 32, Núm. S4, pp. 24-32